YY/T 1224-2014 Active Industry standards-Medicine

YY/T 1224-2014 Detection kit for analysis of related chromosome and gene abnormalities in bladder cancer(Fluorescent in situ hybridization)

Publish Date: 2014-06-17 Implement Date: 2015-07-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Basic Information

Standard Code: YY/T 1224-2014

Standard Type: Industry standards

Standard Status: Active

is_force_gb: no

CCS Name: Medical laboratory equipment

ICS Name: Laboratory medicine

Publish Date: 2014-06-17

Implement Date: 2015-07-01

Pages: 8 pages

Scope

This standard specifies the definition, composition, requirements, test methods, marking, labeling, user's manual, packaging, transportation, and storage of detection kits for chromosomal and genetic abnormalities related to bladder cancer cells (by fluorescence in situ hybridization).
This standard applies to kits composed of four fluorescence in situ hybridization probes and counterstaining agents at corresponding sites of CSP3, CSP7, CSP17, and GLP9, which are used to detect aneuploidy increases in chromosomes 3, 7, and 17 and deletions of the P16 gene locus on chromosome 9 in sample (usually urinary exfoliated cell smears), thereby assisting in the diagnosis of bladder cancer.